


Sarcoma medical oncologist at Dana-Farber


Authors of abstracts will be invited to submit proposals for $25,000 research grants. binaytara.org/projects/confe…

Ran into team sarcoma @TheJimmyFund @DanaFarber after rounds @DrSarcoma @PMerriamMD

FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by @DanaFarber and Brian Wolpin, MD, MPH, of @DanaFarber_Hale

SARC046 is a Phase II trial studying nab-sirolimus in adults with progressing or symptomatic EHE, now enrolling patients at: @DanaFarber @MSKCancerCenter @SitemanCancer @StanfordCancer Visit: clinicaltrials.gov/study/NCT… Special shout outs to @SarcomaAlliance & @wagsmd!

🎗️ Celebrate 30 years of hope with Northwest Sarcoma Foundation! Give $30 for our "$30 for 30 Years" campaign—your gift supports patients, education, and research. No one should face sarcoma alone. Donate: nwsarcoma.org #SarcomaAwareness #DragonslayersUnite #Sarcoma

Approximately 13,900 cases of soft tissue sarcoma and approximately 4,110 cases of bone and joint cancer are expected to be diagnosed in the U.S. Learn more during Sarcoma and Bone Cancer Awareness Month: brnw.ch/21x4fT6

During #SarcomaAwarenessMonth, Bilasan Hammo, MD, shares her experiences since being diagnosed with #EwingSarcoma at age 30 and why @DanaFarber’s Adolescent and Young Adult (AYA)-focused care matters. ➡️bit.ly/4vOhPUR

We need a similar study of GSI for desmoid fibromatosis.
Original Article: Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma (phase 3 ENDURANCE trial) nej.md/3TlfOlb Editorial: Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma nej.md/4wo0Iu9 #Hematology

Sarcoma medical oncologists are amazing people!

I agree! Need to see more of it! Here is a recent pub from Dr. Maitz and his veterinary team, testing Lattice SBRT in dogs 🐶 😍 Link in reply
Leaving Chicago after a productive ASCO26. Easily the best meeting was with Cody for the human-canine sarcoma alliance. 🐶 About 15% of dog cancers are sarcoma, a higher rate than in humans. Help dogs, help people. Better treatments for all. Photo credit @Slade_Mellgard

Leaving Chicago after a productive ASCO26. Easily the best meeting was with Cody for the human-canine sarcoma alliance. 🐶 About 15% of dog cancers are sarcoma, a higher rate than in humans. Help dogs, help people. Better treatments for all. Photo credit @Slade_Mellgard

SARC045 and SARC046 trial in progress posters next to each other. Coincidence? #ASCO26 @SARCtrials


Much anticipated SARC041 results. Should we give abemaciclib first line for liposarcoma?

Encouraging early results with TP53 R175H TCR cell therapy in multiple tumor types including pancreas cancer and a patient with leiomyosarcoma presented by Dr. Rishi Surana @DanaFarberNews ASCO26